Overview

Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia

Status:
Withdrawn
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study aims to compare antiarrhythmic drug therapy with catheter ablation using the SmartTOUCH catheter (Biosense Webster Inc.) as treatment for patients with ventricular tachycardia and coronary artery disease
Phase:
Phase 3
Details
Lead Sponsor:
Newmarket Electrophysiology Research Group Inc
Collaborator:
Biosense Webster, Inc.
Treatments:
Amiodarone
Anti-Arrhythmia Agents
Sotalol